These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37279600)

  • 1. Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobials.
    Skinner AM; Petrella LA; Cheknis A; Johnson S
    J Antimicrob Chemother; 2023 Jul; 78(7):1779-1784. PubMed ID: 37279600
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Camporeale A; Tellapragada C; Kornijenko J; Nord CE; Giske CG
    Microbiol Spectr; 2021 Oct; 9(2):e0144021. PubMed ID: 34612686
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Begum K; Bassères E; Miranda J; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Rashid T; Eyre DW; Wilcox MH; Alam MJ; Garey KW
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
    Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
    Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD; Pfaller MA; Shortridge D; Flamm RK
    J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea.
    Leahy RG; Serio AW; Wright K; Traczewski MM; Tanaka SK
    J Glob Antimicrob Resist; 2022 Sep; 30():96-99. PubMed ID: 35500838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of
    Wieczorkiewicz JT; Skinner AM; Cheknis A; Petrella LA; Stevens VW; Wright LM; Gerding DN; Johnson S
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0069824. PubMed ID: 38953622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
    Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections.
    Zurawski DV; Serio AW; Black C; Pybus B; Akers KS; Deck DH; Johnson S; Chattagul S; Noble SM; Raynor M; Lanteri CA
    Mil Med; 2024 May; 189(5-6):e1353-e1361. PubMed ID: 37963013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
    Lodise TP; Mistry R; Young K; LaPensee K
    Clin Drug Investig; 2021 Mar; 41(3):269-275. PubMed ID: 33604769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of Multidrug-Resistant
    Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
    Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
    Tanaka SK; Steenbergen J; Villano S
    Bioorg Med Chem; 2016 Dec; 24(24):6409-6419. PubMed ID: 27469981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
    Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):143-147. PubMed ID: 29157954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018.
    Dong D; Zheng Y; Chen Q; Guo Y; Yang Y; Wu S; Zhu D; Deng D; Bradford PA; Reinhart H; Hu F
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1559-1572. PubMed ID: 32356026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
    Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
    Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.